लोड हो रहा है...

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma

Inhibition of proteasome, a proteolytic complex responsible for the degradation of ubiquitinated proteins, has emerged as a powerful strategy for treatment of multiple myeloma (MM), a plasma cell malignancy. First-in-class agent, bortezomib, has demonstrated great positive therapeutic efficacy in MM...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Cell Mol Med
मुख्य लेखकों: Kubiczkova, Lenka, Pour, Ludek, Sedlarikova, Lenka, Hajek, Roman, Sevcikova, Sabina
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley & Sons, Ltd 2014
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508135/
https://ncbi.nlm.nih.gov/pubmed/24712303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12279
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!